Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Angor Pectoris

ondansetron has been researched along with Angor Pectoris in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballard, HS1
Bottino, G1
Bottino, J1
Palmer, JB1
Greenstreet, YL1

Other Studies

2 other studies available for ondansetron and Angor Pectoris

ArticleYear
Ondansetron and chest pain.
    Lancet (London, England), 1992, Oct-31, Volume: 340, Issue:8827

    Topics: Aged; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Chest Pain; Female; Humans; M

1992
Ondansetron and chest pain.
    Lancet (London, England), 1992, Dec-05, Volume: 340, Issue:8832

    Topics: Aged; Angina Pectoris; Antineoplastic Agents; Chest Pain; Humans; Neoplasms; Ondansetron; Product La

1992